Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1.
Puimège L, Van Hauwermeiren F, Steeland S, Van Ryckeghem S, Vandewalle J, Lodens S, Dejager L, Vandevyver S, Staelens J, Timmermans S, Vandenbroucke RE, Libert C. Puimège L, et al. Among authors: van hauwermeiren f, van ryckeghem s. EMBO Mol Med. 2015 Aug;7(8):1004-17. doi: 10.15252/emmm.201405010. EMBO Mol Med. 2015. PMID: 25995337 Free PMC article.
Type I interferon drives tumor necrosis factor-induced lethal shock.
Huys L, Van Hauwermeiren F, Dejager L, Dejonckheere E, Lienenklaus S, Weiss S, Leclercq G, Libert C. Huys L, et al. Among authors: van hauwermeiren f. J Exp Med. 2009 Aug 31;206(9):1873-82. doi: 10.1084/jem.20090213. Epub 2009 Aug 17. J Exp Med. 2009. PMID: 19687227 Free PMC article.
Strategies to inhibit the toxicity of systemic TNF treatment.
Van Hauwermeiren F, Puimège L, Vandevyver S, Van Bogaert T, Vanlaere I, Huys L, Dejager L, Libert C. Van Hauwermeiren F, et al. Among authors: van bogaert t. Adv Exp Med Biol. 2011;691:481-4. doi: 10.1007/978-1-4419-6612-4_49. Adv Exp Med Biol. 2011. PMID: 21153352 Review. No abstract available.
RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.
Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T, Declercq W, Libert C, Cauwels A, Vandenabeele P. Duprez L, et al. Among authors: van hauwermeiren f. Immunity. 2011 Dec 23;35(6):908-18. doi: 10.1016/j.immuni.2011.09.020. Immunity. 2011. PMID: 22195746 Free article.
Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases.
Vandenbroucke RE, Dejonckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I, Puimège L, Van Hauwermeiren F, De Rycke R, Mc Guire C, Campestre C, López-Otin C, Matthys P, Leclercq G, Libert C. Vandenbroucke RE, et al. Among authors: van wonterghem e, van hauwermeiren f, van lint p. J Neurosci. 2012 Jul 18;32(29):9805-16. doi: 10.1523/JNEUROSCI.0967-12.2012. J Neurosci. 2012. PMID: 22815495 Free PMC article.
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.
Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P. Takahashi N, et al. Among authors: van hauwermeiren f. Cell Death Dis. 2012 Nov 29;3(11):e437. doi: 10.1038/cddis.2012.176. Cell Death Dis. 2012. PMID: 23190609 Free PMC article.
Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium.
Van Hauwermeiren F, Armaka M, Karagianni N, Kranidioti K, Vandenbroucke RE, Loges S, Van Roy M, Staelens J, Puimège L, Palagani A, Berghe WV, Victoratos P, Carmeliet P, Libert C, Kollias G. Van Hauwermeiren F, et al. Among authors: van roy m. J Clin Invest. 2013 Jun;123(6):2590-603. doi: 10.1172/JCI65624. Epub 2013 May 15. J Clin Invest. 2013. PMID: 23676465 Free PMC article.
33 results